Humanitarian Device Exemption Post-Approval Study of NeuRx Diaphragm Pacing System for Amyotrophic Lateral Sclerosis

NACompletedINTERVENTIONAL
Enrollment

97

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

February 28, 2017

Study Completion Date

February 28, 2017

Conditions
Amyotrophic Lateral Sclerosis (ALS)
Interventions
DEVICE

NeuRx Diaphragm Pacing System (DPS)

The NeuRx DPS is a percutaneous, intramuscular, diaphragm stimulation system which is implanted using standard laparoscopic surgical techniques in an outpatient procedure. The implanted intramuscular diaphragm electrodes are connected to a four channel external stimulator at a percutaneous exit site. DPS is designed to help ALS patients breathe by providing conditioning stimulation of the diaphragm muscles. Recommended frequency of diaphragm conditioning is at least 3 times per day with each session lasting at least 30 minutes. Patients may find it helpful to use the DPS for longer periods to help with breathing. DPS may be used at the same time as non-invasive ventilation. Patents may also sleep with the DPS to assist with breathing difficulties at night.

Trial Locations (11)

11794

Stony Brook University, Stony Brook

27705

Duke University, Durham

32224

Mayo Clinic, Jacksonville

44106

University Hospitals Case Medical Center, Cleveland

60611

Northwestern University, Chicago

66160

University of Kansas Medical Center, Kansas City

68198

University of Nebraska Medical Center, Omaha

80045

University of Colorado Denver, Denver

90048

Cedars-Sinai Medical Center, Los Angeles

94115

California Pacific Medical Center -- Forbes Norris MDA/ALS Research Center, San Francisco

97213

Providence St. Vincent Medical Center, Portland

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Synapse Biomedical

INDUSTRY

NCT01605006 - Humanitarian Device Exemption Post-Approval Study of NeuRx Diaphragm Pacing System for Amyotrophic Lateral Sclerosis | Biotech Hunter | Biotech Hunter